Categories: News

Virbac : Declaration of the number of shares and voting rights 03/2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

Information on the total number of voting rights and of shares representing the share capital
(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité
des Marchés Financiers)

Quotation place: Euronext Paris
Compartiment A
ISIN code: FR0000031577

Date Total number of shares representing the share capital Total number of voting rights
March, 31 2024 8 458 000 Gross total of voting rights : 12 780 944
Net total* of voting rights : 12 692 663

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

VIRBAC: Shaping the future of animal health
NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.com
Website: www.virbac.com

Attachment

Staff

Recent Posts

Abridge Announces Inside for Inpatient and Initial Rollout of Outpatient Orders

SAN FRANCISCO--(BUSINESS WIRE)--Abridge, a leading generative AI platform for clinical conversations, is expanding its capabilities…

16 minutes ago

Netsmart myUnity® Receives CHAP Verification for Home Health

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#CHAPVerification--Netsmart, a leading provider of healthcare solutions and software for post-acute care…

17 minutes ago

CharmHealth Innovation Challenge Returns With $10,000 Prize, Spotlights Agentic AI in Healthcare

Annual Competition Invites Innovators, Entrepreneurs and Developers to Shape the Future of Digital Health With…

3 hours ago

CharmHealth Innovation Challenge Returns With $10,000 Prize, Spotlights Agentic AI in Healthcare

Annual Competition Invites Innovators, Entrepreneurs and Developers to Shape the Future of Digital Health With…

3 hours ago

Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026

COPENHAGEN, Denmark, June 18, 2025 /PRNewswire/ -- Droplet IV today announced the successful completion of…

3 hours ago

Dr. Renuka Kulkarni Joins Gestalt as Chief Medical Officer

SPOKANE, Wash., June 18, 2025 /PRNewswire/ -- Gestalt, a leading provider of AI-powered digital pathology…

3 hours ago